0001213900-23-075375.txt : 20230908
0001213900-23-075375.hdr.sgml : 20230908
20230908160034
ACCESSION NUMBER: 0001213900-23-075375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230904
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rothbard Jonathan B.
CENTRAL INDEX KEY: 0001833968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 231245241
MAIL ADDRESS:
STREET 1: 501 BEALE STREET
STREET 2: UNIT 8D
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-04
0
0001690080
180 Life Sciences Corp.
ATNF
0001833968
Rothbard Jonathan B.
3000 EL CAMINO REAL, BLDG. 4,
SUITE 200
PALO ALTO
CA
94306
0
1
0
0
Chief Scientific Officer
0
Common Stock
28023
D
Stock Option (Right to Buy)
0.67
2023-09-04
4
A
0
15000
0.00
A
2033-09-04
Common Stock
15000
15000
D
The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
/s/ Jonathan B. Rothbard, Ph.D.
2023-09-08